Suppression of HCV‐related HCC by IFN therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1872-034x|45|2|152-161

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.45, Iss.2, 2015-01, pp. : 152-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Interferon Maintenance Therapy Improves Survival in Patients with HCV-Related Hepatocellular Carcinoma after Curative Radiofrequency Ablation

By  

Oncology, Vol. 72, Iss. 1, 2007-12 ,pp. : 132-138

Karger

Access to resources Recommend Favorite

Prevention of Disease Progression with Anti-Inflammatory Therapy in Patients with HCV-Related Cirrhosis: A Markov Model

By  

Oncology, Vol. 86, Iss. 5-6, 2014-06 ,pp. : 295-302

Karger

Access to resources Recommend Favorite

Clinical Characteristics of NonBNonC- HCC: Comparison with HBV and HCV Related HCC

By  

Intervirology, Vol. 50, Iss. 1, 2006-11 ,pp. : 24-31

Karger

Access to resources Recommend Favorite

Baseline sensitivity of T cells to alpha‐IFN correlates with sustained virological response to IFN‐based triple therapy in HCV infection

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 6, 2015-06 ,pp. : 524-534

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bacterial translocation and clinical progression of HCV‐related cirrhosis in HIV‐infected patients

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 25, Iss. 2, 2018-02 ,pp. : 180-186

John Wiley & Sons Inc

Access to resources Recommend Favorite